ResearcherJuntendo UniversityActive in the last 2 years
Yusuke Takasaki
Matched on ORCID iD 0000-0002-5036-4545; OpenAlex author ID A5081385009. Sources: OpenAlex.
Their work
- Papers
- 7
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 10
2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 3 papers · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper
Papers 7
- Evaluation of tumor detection capability for pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasm in each MRI sequence. Co-author DOI 10.4103/sjg.sjg_91_26↗
- Gadoxetic acid-enhanced magnetic resonance imaging predicts early nab-paclitaxel-induced peripheral neuropathy during pancreatic cancer treatment: A pilot stud… Co-author DOI 10.1016/j.jphs.2025.03.009↗
- Pancreatic Adenocarcinoma With Strong Expression of Interleukin-13 Receptor α2 Shows a Poor Response to Gemcitabine-Based Chemotherapy. Co-author DOI 10.1097/mpa.0000000000002151↗
- Effect of Mirogabalin on Chemotherapy-induced Peripheral Neuropathy Caused by Gemcitabine Plus Nab-paclitaxel Therapy in Pancreatic Cancer Patients: A Pilot St… Co-author DOI 10.21203/rs.3.rs-948459/v2↗
- Duration of Reduced CA19-9 Levels Is a Better Prognostic Factor Than Its Rate of Reduction for Unresectable Locally Advanced Pancreatic Cancer. Co-author DOI 10.3390/cancers13164224↗
- IL-13Rα2 Is a Biomarker of Diagnosis and Therapeutic Response in Human Pancreatic Cancer. Co-author DOI 10.3390/diagnostics11071140↗
- Effect of low-dose aspirin use on pancreatic cancer development and morphological changes on imaging in IPMN: A long-term cohort study. Co-author DOI 10.1177/2050640617693524↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Hiroyuki Isayama · 6 shared papers, 2021–2026 · strength 1.02
- Paper Gadoxetic acid-enhanced magnetic resonance imaging predicts early nab-paclitaxel-induced peripheral neuropathy during p… DOI 10.1016/j.jphs.2025.03.009↗
- Paper Evaluation of tumor detection capability for pancreatic ductal adenocarcinoma concomitant with intraductal papillary mu… DOI 10.4103/sjg.sjg_91_26↗
- Paper Pancreatic Adenocarcinoma With Strong Expression of Interleukin-13 Receptor α2 Shows a Poor Response to Gemcitabine-Bas… DOI 10.1097/mpa.0000000000002151↗
- Toshio Fujisawa · 5 shared papers, 2021–2026 · strength 0.72
- Paper Evaluation of tumor detection capability for pancreatic ductal adenocarcinoma concomitant with intraductal papillary mu… DOI 10.4103/sjg.sjg_91_26↗
- Paper Pancreatic Adenocarcinoma With Strong Expression of Interleukin-13 Receptor α2 Shows a Poor Response to Gemcitabine-Bas… DOI 10.1097/mpa.0000000000002151↗
- Paper Effect of Mirogabalin on Chemotherapy-induced Peripheral Neuropathy Caused by Gemcitabine Plus Nab-paclitaxel Therapy i… DOI 10.21203/rs.3.rs-948459/v2↗
- Ko Tomishima · 4 shared papers, 2021–2026 · strength 0.61
- Paper Evaluation of tumor detection capability for pancreatic ductal adenocarcinoma concomitant with intraductal papillary mu… DOI 10.4103/sjg.sjg_91_26↗
- Paper Pancreatic Adenocarcinoma With Strong Expression of Interleukin-13 Receptor α2 Shows a Poor Response to Gemcitabine-Bas… DOI 10.1097/mpa.0000000000002151↗
- Paper Effect of Mirogabalin on Chemotherapy-induced Peripheral Neuropathy Caused by Gemcitabine Plus Nab-paclitaxel Therapy i… DOI 10.21203/rs.3.rs-948459/v2↗
- Yasuhisa Jimbo · 1 shared paper, 2026 · strength 0.22
- Raj K. Puri · 1 shared paper, 2021 · strength 0.12
- Ko Tomishima · 1 shared paper, 2021 · strength 0.11
- Yuya Hisada · 1 shared paper, 2017 · strength 0.07
- Naoyoshi Nagata · 1 shared paper, 2017 · strength 0.07
- Katsunori Sekine · 1 shared paper, 2017 · strength 0.07
- Naomi Uemura · 1 shared paper, 2017 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.